| CT | computed tomography |
| DAB | 3,3′-diaminobenzidine |
| DIILD | drug-induced interstitial lung disease |
| ECM | extracellular matrix |
| FDG | fludeoxyglucose |
| FOV | field of view |
| HRCT | high resolution computed tomography |
| H&E | hematoxylin and Eosin |
| IBs | imaging biomarkers |
| IL | interleukin |
| ILD | interstitial lung disease |
| IPF | idiopathic pulmonary fibrosis |
| i.t. | intratracheal |
| LBIC | Lund university BioImaging Centre |
| LOX | Lysyl Oxidase |
| MMPs | Matrix metallopeptidases |
| MRI | magnetic resonance imaging |
| PET | positron emission tomography |
| ROI | region of interest |
| TGF-β | tissue growth factor β |
| TIMP1 | tissue inhibitor of metalloproteinase 1 |
| TRISTAN-IMI | Translational Imaging in Drug Safety Assessment—Innovative Medicines Initiative |
| UTE | ultra short echo time |